Published in Med J Aust on September 05, 1988
Studies on the transfer of subviral infectivity from SV40-induced hamster tumor cells to indicator cells. Virology (1966) 4.16
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes). Proc Natl Acad Sci U S A (1972) 3.89
To resuscitate or not, that is the question. Med J Aust (1989) 1.93
Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus. Nature (1971) 1.91
Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1967) 1.91
Selective transformation of B lymphocytes by E.B. virus. Lancet (1973) 1.84
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Studies on leukocytes growing in continuous culture derived from normal human donors. J Natl Cancer Inst (1968) 1.80
B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J Natl Cancer Inst (1974) 1.75
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
How far should we investigate and treat prostate cancer? A lawyer's perspective. Med J Aust (1994) 1.71
Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J Virol (1981) 1.54
Confidentiality and the AMA's new code of ethics. Med J Aust (1997) 1.38
Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J Virol (1976) 1.37
Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc Soc Exp Biol Med (1970) 1.37
Infectious mononucleosis: complement-fixing antibodies to herpes-like virus associated with Burkitt lymphoma. Science (1968) 1.30
Biologic and antigenic characteristics of Epstein-Barr virus-related Herpesviruses of chimpanzees and baboons. Int J Cancer (1977) 1.29
Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Proc Soc Exp Biol Med (1972) 1.26
In vitro stimulation of human lymphocytes by Epstein-Barr virus. Cell Immunol (1972) 1.26
DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group. J Virol (1982) 1.24
Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera. J Natl Cancer Inst (1970) 1.19
Symptomatology of late-life minor depression among primary care patients. Psychosomatics (1990) 1.15
Comparative studies of Epstein-Barr virus strains from Ghana and the United States. Int J Cancer (1976) 1.07
Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J Mol Biol (1993) 1.06
Association of EB-virus infection with the post-perfusion syndrome. Lancet (1969) 1.05
HL-A antigens of human lymphoid cells in long-term tissue culture. Transplantation (1969) 1.00
NIH clinical staff conference. Burkitt's tumor. Ann Intern Med (1969) 0.98
The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys. Proc Soc Exp Biol Med (1968) 0.98
Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J Pediatr (1976) 0.96
Attempts to transmit infectious mononucleosis to rhesus monkeys and marmosets and to isolate herpes-like virus. Proc Soc Exp Biol Med (1969) 0.95
Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proc Soc Exp Biol Med (1967) 0.94
Murine leukemia viruses: rupture with ether and detergents to subviral constituents. Natl Cancer Inst Monogr (1966) 0.93
[Humidifier lung]. Schweiz Med Wochenschr (1981) 0.92
Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens. J Immunol (1970) 0.91
Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus. J Clin Microbiol (1982) 0.90
Oncogenic herpesviruses of nonhuman primates. Comp Immunol Microbiol Infect Dis (1979) 0.89
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst (1980) 0.87
Functional hypoglycemia in early latent diabetes. Ann N Y Acad Sci (1968) 0.87
Retention of Teflon particles in hamster lungs: a stereological study. J Aerosol Med (2000) 0.87
Teratogenicity of the newer antiepileptic drugs--the Australian experience. J Clin Neurosci (2011) 0.86
Prenatal cytogenetic diagnosis: some potential legal implications. Med J Aust (1985) 0.86
Epstein-Barr virus and human malignancy. Ann Intern Med (1977) 0.85
Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia (1993) 0.85
Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum (1985) 0.85
Oral excretion of E.B. virus. Lancet (1973) 0.85
Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus. Int J Cancer (1977) 0.83
The effect of thymectomy on response to various antigens of a marsupial Setonix brachyurus (Quokka). Aust J Exp Biol Med Sci (1972) 0.82
Prevalence of depression and its correlates in a general medical practice. J Affect Disord (1987) 0.82
Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob Agents Chemother (2009) 0.82
Isolation of plasma membrane antigens from Epstein-Barr virus-infected lymphoid cells. J Natl Cancer Inst (1973) 0.81
Who has the right to advise children on birth control? Med J Aust (1986) 0.81
Murine leukemia viruses: antigenic studies by quantitative complement fixation. Science (1966) 0.80
Complement-fixing antibodies reactive with Epstein-Barr virus in sera of marmosets and prosimians. Proc Soc Exp Biol Med (1974) 0.80
[Experimental studies of the significance and mechanism of desensitization to the gonadotropin-inhibiting effect of estrogen. 2. Detection and mechanisms of preovulatory desensitization in the ovarian cycle]. Zentralbl Gynakol (1986) 0.79
Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia. J Biomed Opt (2001) 0.79
Infectious mononucleosis in acute leukemia with rising Epstein-Barr virus antibody titers. Ann Intern Med (1970) 0.79
Rational treatment of the obese diabetic. Postgrad Med (1968) 0.79
Heterotransplantation of two human lymphoid cell lines transformed in vitro by Epstein-Barr virus. J Natl Cancer Inst (1971) 0.79
Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines. J Natl Cancer Inst (1982) 0.78
[Hydroxylapatite-coated total prosthesis of the hip]. Helv Chir Acta (1990) 0.78
The case for lamotrigine monitoring in pregnancy. J Clin Neurosci (2006) 0.76
Evidence that inhibition of medial preoptic dopaminergic activity may be involved in the prepubertal desensitization to the negative oestrogen feedback in female rats. Exp Clin Endocrinol (1984) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
Psychiatric symptoms in the elderly in a primary care practice. Gen Hosp Psychiatry (1987) 0.76
Plasma biogenic amine levels in agoraphobia with panic attacks. Pharmacopsychiatry (1987) 0.75
The breast cancer screening controversy continues. Ann Intern Med (1993) 0.75
Plasma serotonin levels in agoraphobia. Am J Psychiatry (1985) 0.75
Functional hypoglycemia, the link between obesity and diabetes. Can Fam Physician (1968) 0.75
Infectious mononucleosis preceding acute myelomonocytic leukemia. Am J Med Sci (1975) 0.75
Gillett's case, the sequel. Intern Med J (2008) 0.75
Urticaria due to blue dye in synthroid tablets. Thyroid (1994) 0.75
[Is pleurodesis for the treatment of spontaneous pneumothorax obsolete?]. Helv Chir Acta (1985) 0.75
Legal liability of public hospitals. Med J Aust (1986) 0.75
[Thyroid and pregnancy]. Schweiz Rundsch Med Prax (1993) 0.75
Once a patient always a patient. Med J Aust (1991) 0.75
[Semiautomatic insulin injection equipment (pens)]. Schweiz Rundsch Med Prax (1990) 0.75
The seizure of medical records. Med J Aust (1985) 0.75
Children and birth control. Med J Aust (1986) 0.75
Compulsory admission of the mentally ill. Med J Aust (1986) 0.75
"Donations" to in-vitro fertilization programmes. Med J Aust (1988) 0.75
Medical negligence and legal causation--where the twain do not meet. Med J Aust (1986) 0.75
Metabolic effects of temocapril in hypertensive patients with diabetes mellitus type 2. J Cardiovasc Pharmacol (1999) 0.75
Viral oncogenicity and viral vaccines--general comments. Natl Cancer Inst Monogr (1968) 0.75
[Experimental pancreatic duct occlusion with polyurethane]. Helv Chir Acta (1989) 0.75
Vasectomies are legal--even in Queensland. Med J Aust (1987) 0.75
Occurrence of Epstein-Barr virus in human leukocyte cultures. In Vitro (1975) 0.75
The right to operate. Med J Aust (1990) 0.75
The explanation of the 1968 Australian outbreak of diphenylhydantoin intoxication. Proc Aust Assoc Neurol (1973) 0.75
The Health Insurance Act and the privilege against self-incrimination. Med J Aust (1985) 0.75
[Nasal polyps and osteolyses]. Praxis (Bern 1994) (2005) 0.75
No hawkers, canvassers or solicitors! Med J Aust (1990) 0.75
New regulations on sterilization. Med J Aust (1990) 0.75
[The cost of anesthesia]. Krankenpfl Soins Infirm (1991) 0.75
Tell it to the Marines. Med J Aust (1985) 0.75
Medical tribunals--a lawyer's nightmare. Med J Aust (1969) 0.75
Mass screening for diabetes using a skin-surface test. J Am Med Womens Assoc (1965) 0.75
The looming storm. Med J Aust (1987) 0.75
"To bury Caesar or to praise him?" The Savage affair as restoration drama. Med J Aust (1986) 0.75
Informed consent--the last of Mrs Sidaway? Med J Aust (1985) 0.75
Oestrogen-induced desensitization to the negative oestrogen feedback. A mechanism involved in the sex-specific control of gonadotrophin secretion during sexual maturation and in adulthood. Monogr Neural Sci (1986) 0.75